<DOC>
	<DOCNO>NCT01400022</DOCNO>
	<brief_summary>Lichen sclerosus rare , chronic cutaneous disorder predilection genital area . Any age group may affect , although see often postmenopausal woman . The current gold standard treatment topical ultrapotent corticosteroid clobetasol . Here compare UVA1 phototherapy 0,05 % clobetasol propionate vaseline treatment vulvar lichen sclerosus .</brief_summary>
	<brief_title>Topical 0.05 % Clobetasol Propionate Vaseline Versus UVA-1 Phototherapy Vulvar Lichen Sclerosus</brief_title>
	<detailed_description>Genital lichen sclerosus rare chronic inflammatory connective tissue disease . The association autoimmune diseases detection autoantibody ECM-1 point autoimmune genesis . Genital lichen sclerosus typically affect woman around menopause . Common sit affection vulva ( clitoris labium majora ) anus woman , prepuce glans penis men . Skin lesion include ivory-white , atrophic , porcelain-like plaque tendency atrophy fissure advance stage . First-line therapy genital lichen sclerosus active , inflammatory phase use topical glucocorticoid . Alternatively , topically apply hormone-containing emollient topical calcineurin inhibitor widely use . However , use topical corticosteroid associate long-term side effect ( atrophy , stria ) limit . In treatment localize scleroderma ( morphea ) , similar sclerosing disease , use ultraviolet radiation ( UVA1 ) prove highly effective . After pilot study , high-dose UVA1 phototherapy ( 120 J / cm ² ) significantly effective low-dose UVA1 ( 20 J / cm ² ) , however difference could find subsequent study . Meanwhile , medium-dose UVA1 phototherapy circumscribe scleroderma determined effective therapy regime included german dermatological guideline ( see also AWMF guideline diagnosis therapy circumscribe scleroderma : http : //www.uni-duesseldorf.de/awmf/ll/013- 066.htm ) .</detailed_description>
	<mesh_term>Lichen Sclerosus et Atrophicus</mesh_term>
	<mesh_term>Vulvar Lichen Sclerosus</mesh_term>
	<mesh_term>Cortisone acetate</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<mesh_term>Cortisone</mesh_term>
	<mesh_term>Petrolatum</mesh_term>
	<criteria>patient genital lichen sclerosus Age &gt; 18 year Willingness participate study No topical steroid within last 4 week Age &lt; 18 year Known photodermatosis ( eg , solar urticaria , polymorphous light eruption ) Known genodermatosis UVsensitivity Treatment photosensitize drug History skin cancer significant UV exposure 3 month study entry application UV radiation therapy outside study conduct UV irradiation : : PUVA , UVA ( include UVA1 ) , UVB ( include SEA ) last 4 week study entry study period</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>lichen</keyword>
	<keyword>sclerosus</keyword>
	<keyword>genital</keyword>
	<keyword>vulvar</keyword>
	<keyword>UVA1</keyword>
</DOC>